Ordaōs creates de novo mini-proteins to help drug hunters deliver life-saving treatments.
Ordaos Bio is a pioneering biotechnology research company dedicated to revolutionizing drug discovery. Located at 101 Avenue of the Americas, 3rd Floor, New York, NY 10013, US, Ordaos Bio is at the forefront of developing innovative solutions for safer and more effective treatments. Ordaos Bio leverages human expertise and machine-driven design to create de novo miniPRO™ proteins, enhancing the capabilities of drug hunters.
With a commitment to advancing medical science, Ordaos Bio focuses on delivering groundbreaking therapies. The company's approach aims to overcome the limitations of traditional discovery methods, providing life-saving treatments to patients in need. Ordaos Bio is dedicated to improving healthcare outcomes through cutting-edge research and development.
Ordaos Bio continues to expand its impact in the biotechnology sector. The company is committed to pushing the boundaries of what's possible in drug design and development. We invite the manager of Ordaos Bio to create a customized and exclusive company showcase and product listing on our platform to further highlight their innovative contributions.
Other organizations in the same industry
This company is also known as